BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Staging
6 results:

  • 1. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: fgfr1 is a promising prognostic marker.
    Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
    BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma.
    Chen Q; Wang J; Chen W; Zhang Q; Wei T; Zhou Y; Xu X; Bai X; Liang T
    Cancer Sci; 2019 Feb; 110(2):530-539. PubMed ID: 30548441
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with pancreatic Ductal Adenocarcinoma.
    Jin W; Xu HX; Zhang SR; Li H; Wang WQ; Gao HL; Wu CT; Xu JZ; Qi ZH; Li S; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2019 Feb; 26(2):635-643. PubMed ID: 30374923
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metformin as an Adjunctive Therapy for pancreatic cancer: A Review of the Literature on Its Potential Therapeutic Use.
    Broadhurst PJ; Hart AR
    Dig Dis Sci; 2018 Nov; 63(11):2840-2852. PubMed ID: 30159732
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
    Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
    Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of pancreatic Neuroendocrine Tumors.
    Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.